These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 15510833

  • 1. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K, Hashino S, Shimizu K, Yonezumi M, Chiba K, Kondo T, Suzuki S, Imamura M, Asaka M.
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [Abstract] [Full Text] [Related]

  • 2. [Cyclosporin A withdrawal causes spontaneous remission of recurrent subcutaneous tumors after allogeneic peripheral blood stem cell transplantation for adult T-cell leukemia/lymphoma].
    Ohguchi H, Sai T, Hamazaki Y, Hiwatashi K.
    Rinsho Ketsueki; 2003 Feb; 44(2):102-7. PubMed ID: 12692982
    [Abstract] [Full Text] [Related]

  • 3. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kojima R, Kami M, Kim SW, Murashige N, Kishi Y, Hori A, Imataki O, Hamaki T, Sakiyama M, Masuo S, Fujisawa Y, Makimoto A, Heike Y, Tanosaki R, Takaue Y.
    Bone Marrow Transplant; 2003 Aug; 32(4):439-42. PubMed ID: 12900783
    [Abstract] [Full Text] [Related]

  • 4. [Graft-versus-ATLL effect induced by abrupt discontinuation of immunosuppression following allogeneic bone marrow transplantation].
    Hara S, Yokote T, Akioka T, Oka S, Yamano T, Tsuji M, Hanafusa T.
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):867-71. PubMed ID: 15984534
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 Jun; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 6. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H, Kitaori K, Kasai M, Shimokawa T, Kato C, Yamanishi H, Ueda R, Morishima Y.
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [Abstract] [Full Text] [Related]

  • 7. [Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia].
    Okamura K, Ikeda T, Shimakura Y, Yoshiba F, Kishi K, Ando K, Hotta T.
    Rinsho Ketsueki; 2005 Jul; 46(7):527-31. PubMed ID: 16440747
    [Abstract] [Full Text] [Related]

  • 8. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B.
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [Abstract] [Full Text] [Related]

  • 9. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B, Li DP, Xu KL, Pan XY.
    Chin Med J (Engl); 2005 Mar 20; 118(6):474-9. PubMed ID: 15788128
    [Abstract] [Full Text] [Related]

  • 10. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
    Cesaro S, Pillon M, Visintin G, Putti MC, Gazzola MV, D'Amore E, Scarzello G, Zanesco L, Messina C, Rosolen A.
    Eur J Haematol; 2005 Jul 20; 75(1):22-6. PubMed ID: 15946306
    [Abstract] [Full Text] [Related]

  • 11. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct 20; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 12. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C, Benyunes MC, Sale G, Beauchamp M, York A, Thompson JA, Buckner CD, Fefer A.
    Bone Marrow Transplant; 1996 Mar 20; 17(3):351-6. PubMed ID: 8704686
    [Abstract] [Full Text] [Related]

  • 13. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug 20; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 14. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
    Kuroki F, Goto H, Yanagimachi M, Kajiwara R, Fujii H, Isaki S, Takahashi H, Ikuta K, Yokota S.
    Rinsho Ketsueki; 2006 Jul 20; 47(7):639-44. PubMed ID: 16910574
    [Abstract] [Full Text] [Related]

  • 15. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J, Powles R, Singhal S, Iveson T, Treleaven J, Catovsky D.
    Bone Marrow Transplant; 1996 Mar 20; 17(3):371-5. PubMed ID: 8704689
    [Abstract] [Full Text] [Related]

  • 16. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G, Truitt RL, Johnson BD.
    Biol Blood Marrow Transplant; 2006 Apr 20; 12(4):397-407. PubMed ID: 16545723
    [Abstract] [Full Text] [Related]

  • 17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

  • 18. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Jan 15; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 20. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH, Huang XJ, Liu KY, Xu LP, Liu DH, Chen H, Chen YH, Wang JZ, Han W, Lu DP.
    Chin Med J (Engl); 2007 Mar 20; 120(6):463-8. PubMed ID: 17439737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.